Article

Knowledge is Power: A Cancer Patient Navigates Her Diagnosis

The first few weeks following a cancer diagnosis can be the most challenging.

Knowledge is power.

This belief has driven how I respond to stressful situations throughout my life.

When I was pregnant with our first child I took every class I could find, read stacks of books, and watched many hours of birth videos (thanks to my midwife sister).

I focused. I studied. I prepared.

When I found out that our second pregnancy was twins, I read books and asked questions of every twin I knew. As the pregnancy progressed and took a complicated turn, we were told that the girls may be born severely premature and if they survived they would face a lifetime of challenges. In response, I started reading about raising children with special needs. I subscribed to blogs written by some amazing families with special children. I got ready for every possible scenario.

I focused. I studied. I prepared.

When I was diagnosed with metastatic lung cancer, I dove into the research and tried to learn everything I could about this disease.

Actually, that's not quite true.

For the first few weeks I was in a fog of confusion, denial, shock. In those early days I felt completely frozen. It was as though there was an avalanche of emotion waiting to engulf me, and any wrong move could set it off. I couldn't even listen to music, because the feeling of the notes caused the ground around me to vibrate and I knew if it shook too hard the walls would collapse and I would be crushed under the weight of my reality.

For the first few weeks I actively avoided reading anything about lung cancer. I knew enough to understand how dire my situation was. I couldn't face seeing it in black and white.

I had to absorb the news in tiny droplets, taking in a little bit more every day. Drop by drop, I started to accept it. As the weeks went on, I started to face my diagnosis. My coping mechanism for tough situations had always been to seek out knowledge and turn to information for comfort.

I took a deep breath and started reading.

And what I read was scary. The stats were bleak, and they were staring back at me unblinking from the page.

I knew that I had non-small cell lung cancer.

I knew that I was only 37 years old.

I knew that I had three kids under the age of 5.

I knew that I may not be around to see them grow up.

I knew that it had spread from my left lung to my ribs, my spine, my hip, and my liver.

I knew that there was no cure.

I knew that I had a really rough road ahead of me.

I knew that I was ready to take the first step on that path.

Related Videos
Image of man with black hair.
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Related Content